prednisolone has been researched along with Nevoxanthoendothelioma in 4 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, TK | 1 |
| Jung, TY | 1 |
| Baek, HJ | 1 |
| Kim, SK | 1 |
| Lee, KH | 1 |
| Yun, SJ | 1 |
| Manjandavida, FP | 1 |
| Arepalli, S | 1 |
| Tarlan, B | 1 |
| Shields, CL | 1 |
| De Keyser, C | 1 |
| Maudgal, P | 1 |
| Legius, E | 1 |
| Van Ginderdeuren, R | 1 |
| Casteels, I | 1 |
| Dölken, R | 1 |
| Weigel, S | 1 |
| Schröder, H | 1 |
| Hartwig, M | 1 |
| Harms, D | 1 |
| Beck, JF | 1 |
4 other studies available for prednisolone and Nevoxanthoendothelioma
| Article | Year |
|---|---|
Disseminated juvenile xanthogranuloma occurring after treatment of Langerhans cell histiocytosis: a case report.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Brain; Child; Follow | 2018 |
Optical coherence tomography characteristics of epi-iridic membrane in a child with recurrent hyphema and presumed juvenile xanthogranuloma.
Topics: Administration, Topical; Basement Membrane; Female; Fluorescein Angiography; Glucocorticoids; Humans | 2014 |
Juvenile xanthogranuloma of the corneoscleral limbus: report of two cases.
Topics: Betamethasone; Child, Preschool; Combined Modality Therapy; Corneal Diseases; Female; Glucocorticoid | 2011 |
Treatment of severe disseminated juvenile systemic xanthogranuloma with multiple lesions in the central nervous system.
Topics: Central Nervous System Diseases; Combined Modality Therapy; Craniotomy; Drug Therapy, Combination; F | 2006 |